Hiroki Inoue

Hiroki Inoue has extensive experience in the pharmaceutical industry, currently serving as General Manager and Head of the Business Development Group at Ajinomoto Co., Inc. since February 2010, alongside a role as Senior Researcher. Prior to this, Hiroki Inoue worked as a Research Scientist at Eli Lilly's Singapore Centre for Drug Discovery since June 2009. Earlier career highlights include a position as Team Leader in the Molecular Profiling Team at Banyu Pharmaceuticals, and as a Research Scientist in the Metabolic Virus Group at GlaxoSmithKline, where significant achievements include the establishment of animal models and a biomarker portfolio for anti-diabetic and anti-obesity drug screening. Hiroki Inoue holds a Master's degree in Biotechnology from Tokyo Institute of Technology, obtained in 2000.